BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: dos Santos ALS. HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos. World J Biol Chem 2010; 1(2): 21-30 [PMID: 21537366 DOI: 10.4331/wjbc.v1.i2.21]
URL: https://www.wjgnet.com/1949-8454/full/v1/i2/21.htm
Number Citing Articles
1
Sławomir Milewski. Candida albicans: Cellular and Molecular Biology2017; : 429 doi: 10.1007/978-3-319-50409-4_21
2
Mariusz Gogol, Oliwia Bochenska, Marcin Zawrotniak, Justyna Karkowska-Kuleta, Dorota Zajac, Maria Rapala-Kozik. Pathophysiological Aspects of Proteases2017; : 353 doi: 10.1007/978-981-10-6141-7_15
3
Letícia Silveira Goulart, Werika Weryanne Rosa de Souza, Camila Aoyama Vieira, Janaina Sousa de Lima, Ricardo Alves de Olinda, Claudinéia de Araújo. Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility studyEinstein (São Paulo) 2018; 16(3) doi: 10.1590/s1679-45082018ao4224
4
Shanthini Kalimuthu, Om Alkhir Alshanta, Akshaya Lakshmi Krishnamoorthy, Akhila Pudipeddi, Adline Princy Solomon, William McLean, Yiu Yan Leung, Gordon Ramage, Prasanna Neelakantan. Small molecule based anti-virulence approaches against Candida albicans infectionsCritical Reviews in Microbiology 2022; 48(6): 743 doi: 10.1080/1040841X.2021.2025337
5
Karina M. Rebello, Valter V. Andrade-Neto, Claudia Regina B. Gomes, Marcos Vinícius N. de Souza, Marta H. Branquinha, André L. S. Santos, Eduardo Caio Torres-Santos, Claudia M. d'Avila-Levy. Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo ApproachesFrontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00229
6
Marjan A. Rafiee. Anti‐Coronavirus Activity of Certain Herbacetin Derivatives, A Theoretical StudyChemistrySelect 2024; 9(15) doi: 10.1002/slct.202303477
7
Vishnu Menon, Mala Rao. A low-molecular-mass aspartic protease inhibitor from a novel Penicillium sp.: implications in combating fungal infectionsMicrobiology 2012; 158(7): 1897 doi: 10.1099/mic.0.058511-0
8
Om Alkhir Alshanta, Khawlah Albashaireh, Emily McKloud, Christopher Delaney, Ryan Kean, William McLean, Gordon Ramage. Candida albicans and Enterococcus faecalis biofilm frenemies: When the relationship soursBiofilm 2022; 4: 100072 doi: 10.1016/j.bioflm.2022.100072
9
Małgorzata Bondaryk, Zbigniew Ochal, Monika Staniszewska. Comparison of anti-Candida albicans activities of halogenomethylsulfonyl derivativesMedicinal Chemistry Research 2015; 24(5): 1799 doi: 10.1007/s00044-014-1258-8
10
André L. S. Santos, Lys A. Braga-Silva, Bianca A. Silva, Vanila F. Palmeira, Roberta S. Valle, Érika A. Abi-chacra, Vanessa S. Oliveira, Roberto D. Lins, Lucimar F. Kneipp, Cátia L. Sodré. Proteases in Health and Disease2013; : 89 doi: 10.1007/978-1-4614-9233-7_7
11
J.J.C. Sidrim, L.V. Perdigão-Neto, R.A. Cordeiro, R.S.N. Brilhante, J.J.G. Leite, C.E.C. Teixeira, A.J Monteiro, R.M.F. Freitas, J.F. Ribeiro, J.R.L. Mesquita, M.V.F. Gonçalves, M.F.G. Rocha. Viral protease inhibitors affect the production of virulence factors inCryptococcus neoformansCanadian Journal of Microbiology 2012; 58(7): 932 doi: 10.1139/w2012-075
12
Cristina Nicoleta Ciurea, Irina-Bianca Kosovski, Felicia Toma, Mihai Mareș, Bianca Tudor, Adrian Man. Mediation of Candida species growth and virulence by the proinflammatory cytokine IL-6Acta Marisiensis - Seria Medica 2021; 67(4): 204 doi: 10.2478/amma-2021-0036
13
Raimunda Sâmia Nogueira Brilhante, José Alexandre Telmos Silva, Géssica dos Santos Araújo, Vandbergue Santos Pereira, Wilker Jose Perez Gotay, Jonathas Sales de Oliveira, Glaucia Morgana de Melo Guedes, Waldemiro Aquino Pereira-Neto, Débora de Souza Collares Maia Castelo-Branco, Rossana de Aguiar Cordeiro, José Júlio Costa Sidrim, Marcos Fábio Gadelha Rocha. Darunavir inhibits Cryptococcus neoformans/Cryptococcus gattii species complex growth and increases the susceptibility of biofilms to antifungal drugsJournal of Medical Microbiology 2020; 69(6): 830 doi: 10.1099/jmm.0.001194
14
Rossana de Aguiar Cordeiro, Rosana Serpa, Patrícia Bruna Leite Mendes, Antonio José de Jesus Evangelista, Ana Raquel Colares Andrade, Jônatas da Silva Franco, Vandbergue dos Santos Pereira, Lucas Pereira de Alencar, Jonathas Sales de Oliveira, Zoilo Pires de Camargo, Reginaldo Gonçalves de Lima Neto, Débora de Souza Collares Maia Castelo-Branco, Raimunda Samia Nogueira Brilhante, Marcos Fabio Gadelha Rocha, José Júlio Costa Sidrim. The HIV aspartyl protease inhibitor ritonavir impairs planktonic growth, biofilm formation and proteolytic activity inTrichosporonspp.Biofouling 2017; 33(8): 640 doi: 10.1080/08927014.2017.1350947
15
Amalanathan Veni, T. Sivaswamy Lokeswari, Dhanapal Pavithra, Thennavan Sugapriya. Melianone inhibits Secreted Aspartic Proteases (SAP), a Virulence Factor During Hyphal Formation in Candida albicansCurrent Computer-Aided Drug Design 2022; 18(5): 327 doi: 10.2174/1573409918666220818120645
16
Vanessa V. S. Castilho, Keyla C. S. Gonçalves, Karina M. Rebello, Luiz P. R. Baptista, Leandro S. Sangenito, Helena L. C. Santos, Marta H. Branquinha, André L. S. Santos, Rubem F. S. Menna-Barreto, Ana C. Guimarães, Claudia M. d’Avila-Levy. Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidaseBMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3927-z
17
Menizibeya Osain Welcome. Gastrointestinal Physiology2018; : 871 doi: 10.1007/978-3-319-91056-7_12
18
Brandon Havranek, Shahidul M. Islam. An in silico approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease Journal of Biomolecular Structure and Dynamics 2021; 39(12): 4304 doi: 10.1080/07391102.2020.1776158
19
Karina M. Rebello, Valter V. Andrade-Neto, Aline A. Zuma, Maria Cristina M. Motta, Claudia Regina B. Gomes, Marcus Vinícius N. de Souza, Geórgia C. Atella, Marta H. Branquinha, André L. S. Santos, Eduardo Caio Torres-Santos, Claudia M. d'Avila-Levy. Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism ofLeishmania amazonensispromastigotesParasitology 2018; 145(10): 1304 doi: 10.1017/S0031182018000823
20
André Luis Souza dos Santos. Protease expression by microorganisms and its relevance to crucial physiological/pathological eventsWorld Journal of Biological Chemistry 2011; 2(3): 48-58 doi: 10.4331/wjbc.v2.i3.48
21
Monika Staniszewska, Małgorzata Bondaryk, Zbigniew Ochal. Susceptibility of Candida albicans to New Synthetic Sulfone DerivativesArchiv der Pharmazie 2015; 348(2): 132 doi: 10.1002/ardp.201400360
22
Wenli Feng, Jing Yang, Yan Ma, Zhiqin Xi, Xiaoqin Zhao, Xiaoxia Zhao, Min Zhao. The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11Immunity, Inflammation and Disease 2021; 9(3): 667 doi: 10.1002/iid3.415
23
Anmol Kulshrestha, Pratima Gupta. Secreted aspartyl proteases family: a perspective review on the regulation of fungal pathogenesisFuture Microbiology 2023; 18(5): 295 doi: 10.2217/fmb-2022-0143
24
Gunderao Hanumantrao Kathwate, S. Mohan Karuppayil. Antifungal properties of the anti-hypertensive drug: AliskirenArchives of Oral Biology 2013; 58(9): 1109 doi: 10.1016/j.archoralbio.2013.02.006
25
Luiz R. Travassos, Carlos P. Taborda. Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine CandidatesFrontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00224
26
Vanila F. Palmeira, Fatima R. V. Goulart, Marcela Q. Granato, Daniela S. Alviano, Celuta S. Alviano, Lucimar F. Kneipp, André L. S. Santos. Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase InhibitorsFrontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.01383
27
Ayodeji A. Agbowuro, Wilhelmina M. Huston, Allan B. Gamble, Joel D. A. Tyndall. Proteases and protease inhibitors in infectious diseasesMedicinal Research Reviews 2018; 38(4): 1295 doi: 10.1002/med.21475
28
Marcela Q. Granato, Ingrid S. Sousa, Thabatta L. S. A. Rosa, Diego S. Gonçalves, Sergio H. Seabra, Daniela S. Alviano, Maria C. V. Pessolani, André L. S. Santos, Lucimar F. Kneipp. Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interactionJournal of Enzyme Inhibition and Medicinal Chemistry 2020; 35(1): 629 doi: 10.1080/14756366.2020.1724994